Europe · Wires & real time · Reuters Europe Markets

South Africa's Aspen Pharmacare to sell women's health product in Europe to Ennogen

Published by Reuters Europe Markets · United Kingdom 15 h ago

South Africa's Aspen Pharmacare will sell the European commercialisation rights and related intellectual property for its women's health ‌product Ovestin to Ennogen Healthcare…

Read the full article on Reuters Europe Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

TASS

South Africa's Aspen Pharmacare to sell women's health product in Europe to Ennogen

Share

Also worth reading

One killed, eight wounded in Ukraine’s attack on commuter bus in LPR

Brent crude falls nearly 8% below $105 as US-Iran diplomacy eases supply fears

Fastmarkets clarifies China domestic steel scrap methodology guide

Binance hack plays up crypto’s trust issues

Merz says Germany must preserve 'digital sovereignty' in AI era

Apple's new CEO Ternus to face first earnings test as memory costs surge